Guangdong Biolight Meditech Co Ltd. Stock Analysis 300246.SZ

Guangdong Biolight Meditech Co., Ltd. engages in the research, development, production, sale, and service of medical device products. The company is headquartered in Zhuhai, Guangdong and currently employs 1,242 full-time employees. The company went IPO on 2011-07-19. The main products of the life information and support segment are monitors, electrocardiographs, infusion pumps, pulse oximeters, central monitoring systems, wearable medical products and others. The main products of the kidney disease medical segment are hemodialysis equipment (machines), hemodialyzers, dialysate filters, dialysis circuits, puncture needles, disinfectants, dialysis water equipment, disinfection systems, concentrated liquid centralized distribution and supply systems and others. The firm mainly operates its businesses in the domestic and overseas markets.